These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29086069)

  • 61. Quality of life and functional disability in patients with interstitial lung disease related to Systemic Sclerosis.
    Lumetti F; Barone L; Alfieri C; Silva M; Serra V; Delsante G; Sverzellati N; Ariani A
    Acta Biomed; 2015 Sep; 86(2):142-8. PubMed ID: 26422428
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers.
    Del Rosso A; Boldrini M; D'Agostino D; Placidi GP; Scarpato A; Pignone A; Generini S; Konttinen Y; Zoppi M; Vlak T; Placidi G; Matucci-Cerinic M
    Arthritis Rheum; 2004 Jun; 51(3):475-81. PubMed ID: 15188336
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
    Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
    Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pain, fatigue and functional disability are associated with higher educational needs in systemic sclerosis: a cross-sectional study.
    Sierakowska M; Sierakowski S; Sierakowska J; Krajewska-Kułak E; Ndosi M
    Rheumatol Int; 2018 Aug; 38(8):1471-1478. PubMed ID: 29497844
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease.
    Michalska-Jakubus M; Kowal-Bielecka O; Chodorowska G; Bielecki M; Krasowska D
    Rheumatology (Oxford); 2011 Apr; 50(4):746-55. PubMed ID: 21149250
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hair cortisol as a marker of hypothalamic-pituitary-adrenal Axis activity in female patients with major depressive disorder.
    Pochigaeva K; Druzhkova T; Yakovlev A; Onufriev M; Grishkina M; Chepelev A; Guekht A; Gulyaeva N
    Metab Brain Dis; 2017 Apr; 32(2):577-583. PubMed ID: 28064407
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relationship between interleukin-6 and cardiac involvement in systemic sclerosis.
    Jurisic Z; Martinovic-Kaliterna D; Marasovic-Krstulovic D; Perkovic D; Tandara L; Salamunic I; Carevic V
    Rheumatology (Oxford); 2013 Jul; 52(7):1298-302. PubMed ID: 23538743
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lack of correlation of the health assessment questionnaire disability index with lung parameters in systemic sclerosis associated pulmonary arterial hypertension.
    Chow S; Pope JE; Mehta S
    Clin Exp Rheumatol; 2008; 26(6):1012-7. PubMed ID: 19210864
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis.
    Nietert PJ; Mitchell HC; Bolster MB; Curran MY; Tilley BC; Silver RM
    J Rheumatol; 2005 Jan; 32(1):51-7. PubMed ID: 15630725
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction.
    Fiori G; Marzi T; Bartoli F; Bruni C; Ciceroni C; Palomba M; Zolferino M; Corsi E; Galimberti M; Moggi Pignone A; Viggiano MP; Guiducci S; Calamai M; Matucci-Cerinic M
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):135-141. PubMed ID: 30277859
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A cross-sectional comparison of three self-reported functional indices in scleroderma.
    Smyth AE; MacGregor AJ; Mukerjee D; Brough GM; Black CM; Denton CP
    Rheumatology (Oxford); 2003 Jun; 42(6):732-8. PubMed ID: 12730528
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Results of the Health Assessment Questionnaire for Japanese patients with systemic sclerosis--measuring functional impairment in systemic sclerosis versus other connective tissue diseases.
    Morita Y; Muro Y; Sugiura K; Tomita Y; Tamakoshi K
    Clin Exp Rheumatol; 2007; 25(3):367-72. PubMed ID: 17631731
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk.
    De Luca G; Bosello SL; Berardi G; Rucco M; Canestrari G; Correra M; Mirone L; Forni F; Di Mario C; Danza FM; Pirronti T; Ferraccioli G
    Rheumatology (Oxford); 2015 Nov; 54(11):1991-9. PubMed ID: 26106211
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association between the serum level of vitamin D and systemic sclerosis in a Chinese population: a case control study.
    Zhang L; Duan Y; Zhang TP; Huang XL; Li BZ; Ye DQ; Wang J
    Int J Rheum Dis; 2017 Aug; 20(8):1002-1008. PubMed ID: 26619796
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis.
    Khanna D; Furst DE; Wong WK; Tsevat J; Clements PJ; Park GS; Postlethwaite AE; Ahmed M; Ginsburg S; Hays RD;
    Qual Life Res; 2007 Aug; 16(6):1083-92. PubMed ID: 17404896
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Serum apelin levels: clinical association with vascular involvements in patients with systemic sclerosis.
    Aozasa N; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):37-42. PubMed ID: 22112232
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group.
    Jaeger VK; Distler O; Maurer B; Czirják L; Lóránd V; Valentini G; Vettori S; Del Galdo F; Abignano G; Denton C; Nihtyanova S; Allanore Y; Avouac J; Riemekasten G; Siegert E; Huscher D; Matucci-Cerinic M; Guiducci S; Frerix M; Tarner IH; Garay Toth B; Fankhauser B; Umbricht J; Zakharova A; Mihai C; Cozzi F; Yavuz S; Hunzelmann N; Rednic S; Vacca A; Schmeiser T; Riccieri V; García de la Peña Lefebvre P; Gabrielli A; Krummel-Lorenz B; Martinovic D; Ancuta C; Smith V; Müller-Ladner U; Walker UA
    Rheumatology (Oxford); 2018 Mar; 57(3):441-450. PubMed ID: 28499034
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms.
    Thombs BD; Fuss S; Hudson M; Schieir O; Taillefer SS; Fogel J; Ford DE; Baron M;
    Arthritis Rheum; 2008 Mar; 59(3):431-7. PubMed ID: 18311765
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Nutritional evaluation and physical functional ability in scleroderma patients].
    Azevedo VF; Müller Cde S; Rinaldi L; Bredt MC; Giovanni K; Pereira MA; Volaco FC
    Acta Reumatol Port; 2009; 34(2A):228-34. PubMed ID: 19569278
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Translation and validation of the Persian version of the scleroderma health assessment questionnaire (SHAQ).
    Nayebirad S; Emamzade A; Sedaghat M; Montazeri A; Gharibdoost F; Yaseri M; Tamartash Z; Salehi S; Kiani T; Soltani S; Mohammadzadegan A; Eshaghi A; Madanipour MR; Atef Yekta R; Kavosi H
    Intern Emerg Med; 2023 Apr; 18(3):811-819. PubMed ID: 36854998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.